Magenta Therapeutics Inc (MGTA)
Stock chart
Earnings
Value bought
Past 90 days
Value sold
Past 90 days
Net insiders buying
Past 90 days
Trades (buy and sell)
Past 90 days
Search
| Notification date | Transaction date | B/S Transaction type | Insider and/or position |
Nb. shares Price Value |
Number of shares | Price | Value | Details |
|---|---|---|---|---|---|---|---|---|
| 2023-10-03 | 2023-09-29 | B Purchase |
Fairmount Funds Management LLC Non-Executive Director Large shareholder |
24,670
+1.3%
13.63USD 336,252 |
24,670 +1.3% | 13.63 | USD 336,252 | |
| 2023-09-28 | 2023-09-26 | B Purchase |
Fairmount Funds Management LLC Non-Executive Director Large shareholder |
30,000
+1.6%
13.15USD 394,500 |
30,000 +1.6% | 13.15 | USD 394,500 | |
| 2023-09-25 | 2023-09-22 | B Purchase |
Chief Medical Officer Officer |
2,000
+100.0%
13.20USD 26,400 |
2,000 +100.0% | 13.20 | USD 26,400 | |
| 2023-09-25 | 2023-09-21 | B Purchase |
Chief Medical Officer Officer |
2,000
+inf%
13.20USD 26,400 |
2,000 +inf% | 13.20 | USD 26,400 | |
| 2023-09-21 | 2023-09-19 | B Purchase |
Fairmount Funds Management LLC Non-Executive Director Large shareholder |
30,000
+1.6%
13.20USD 396,000 |
30,000 +1.6% | 13.20 | USD 396,000 | |
| 2023-09-13 | 2023-09-13 | B Purchase |
Fairmount Funds Management LLC Non-Executive Director Large shareholder |
9,367
+0.5%
11.76USD 110,156 |
9,367 +0.5% | 11.76 | USD 110,156 | |
| 2023-09-13 | 2023-09-12 | B Purchase |
Fairmount Funds Management LLC Non-Executive Director Large shareholder |
14,887
+0.8%
10.85USD 161,524 |
14,887 +0.8% | 10.85 | USD 161,524 | |
| 2023-02-09 | 2023-02-08 | S Sale | Large shareholder |
1,500,000
-32.9%
0.82USD 1,230,000 |
1,500,000 -32.9% | 0.82 | USD 1,230,000 | |
| 2023-02-09 | 2023-02-07 | S Sale | Large shareholder |
2,200,000
-32.6%
0.83USD 1,826,000 |
2,200,000 -32.6% | 0.83 | USD 1,826,000 | |
| 2020-07-01 | 2020-06-29 | B Purchase | Non-Executive Director |
1,250,000
+inf%
8.00USD 10,000,000 |
1,250,000 +inf% | 8.00 | USD 10,000,000 | |
| 2020-01-10 | 2020-01-10 | PS Planned sale |
See Remarks |
11,200
-4.3%
15.25USD 170,800 |
11,200 -4.3% | 15.25 | USD 170,800 | |
| 2020-01-03 | 2020-01-02 | PS Planned sale |
See Remarks |
2,800
-1.1%
15.10USD 42,280 |
2,800 -1.1% | 15.10 | USD 42,280 | |
| 2020-01-03 | 2020-01-02 | PS Planned sale |
Chief Medical Officer |
11,294
-57.6%
15.04USD 169,817 |
11,294 -57.6% | 15.04 | USD 169,817 | |
| 2019-12-26 | 2019-12-24 | PS Planned sale |
ISACSON CHRISTINA K. Chief Business Officer |
4,463
-5.1%
16.01USD 71,453 |
4,463 -5.1% | 16.01 | USD 71,453 | |
| 2019-12-26 | 2019-12-24 | PS Planned sale |
ZDRAVESKI ZORAN See Remarks |
7,902
-5.8%
16.00USD 126,432 |
7,902 -5.8% | 16.00 | USD 126,432 | |
| 2019-12-26 | 2019-12-23 | PS Planned sale |
ZDRAVESKI ZORAN See Remarks |
4,181
-3.0%
16.03USD 67,021 |
4,181 -3.0% | 16.03 | USD 67,021 | |
| 2019-12-26 | 2019-12-23 | PS Planned sale |
ISACSON CHRISTINA K. Chief Business Officer |
9,867
-10.1%
16.03USD 158,168 |
9,867 -10.1% | 16.03 | USD 158,168 | |
| 2019-12-23 | 2019-12-23 | PS Planned sale |
See Remarks |
2,897
-1.1%
15.10USD 43,755 |
2,897 -1.1% | 15.10 | USD 43,755 | |
| 2019-12-20 | 2019-12-20 | PS Planned sale |
See Remarks |
76,711
-22.2%
15.16USD 1,162,617 |
76,711 -22.2% | 15.16 | USD 1,162,617 | |
| 2019-12-20 | 2019-12-20 | PS Planned sale |
DAVIS JOHN C. JR Chief Medical Officer |
919
-10.0%
15.00USD 13,785 |
919 -10.0% | 15.00 | USD 13,785 | |
| 2019-12-13 | 2019-12-10 | PS Planned sale |
See Remarks |
4,392
-1.3%
15.10USD 66,319 |
4,392 -1.3% | 15.10 | USD 66,319 | |
| 2019-12-11 | 2019-12-10 | PS Planned sale |
DAVIS JOHN C. JR Chief Medical Officer |
17,055
-67.3%
15.00USD 255,825 |
17,055 -67.3% | 15.00 | USD 255,825 | |
| 2019-12-11 | 2019-12-09 | PS Planned sale |
DAVIS JOHN C. JR Chief Medical Officer |
4,614
-35.7%
15.00USD 69,210 |
4,614 -35.7% | 15.00 | USD 69,210 | |
| 2019-12-02 | 2019-12-02 | S Sale |
Chief Scientific Officer |
2,500
-1.0%
13.21USD 33,036 |
2,500 -1.0% | 13.21 | USD 33,036 | |
| 2019-12-02 | 2019-12-02 | S Sale |
Chief Scientific Officer |
1,373
-0.6%
13.31USD 18,279 |
1,373 -0.6% | 13.31 | USD 18,279 | |
| 2019-12-02 | 2019-12-02 | S Sale |
Chief Scientific Officer |
3,627
-1.5%
12.74USD 46,205 |
3,627 -1.5% | 12.74 | USD 46,205 | |
| 2019-11-25 | 2019-11-20 | S Sale |
Chief Scientific Officer |
5,000
-2.0%
12.00USD 60,000 |
5,000 -2.0% | 12.00 | USD 60,000 | |
| 2019-11-01 | 2019-11-01 | S Sale |
Chief Scientific Officer |
5,000
-1.9%
10.67USD 53,334 |
5,000 -1.9% | 10.67 | USD 53,334 | |
| 2019-10-03 | 2019-10-01 | S Sale |
Chief Scientific Officer |
5,000
-1.9%
10.01USD 50,064 |
5,000 -1.9% | 10.01 | USD 50,064 | |
| 2019-09-19 | 2019-09-19 | PS Planned sale |
Chief Scientific Officer |
1,656
-0.6%
12.00USD 19,872 |
1,656 -0.6% | 12.00 | USD 19,872 | |
| 2019-09-16 | 2019-09-12 | PS Planned sale |
Chief Scientific Officer |
844
-0.3%
12.00USD 10,128 |
844 -0.3% | 12.00 | USD 10,128 | |
| 2019-09-04 | 2019-09-03 | PS Planned sale |
Chief Scientific Officer |
5,000
-1.8%
10.11USD 50,531 |
5,000 -1.8% | 10.11 | USD 50,531 | |
| 2019-08-01 | 2019-08-01 | PS Planned sale |
Chief Scientific Officer |
2,500
-0.9%
13.41USD 33,523 |
2,500 -0.9% | 13.41 | USD 33,523 | |
| 2019-08-01 | 2019-08-01 | PS Planned sale |
Chief Scientific Officer |
5,000
-1.8%
13.42USD 67,109 |
5,000 -1.8% | 13.42 | USD 67,109 | |
| 2019-07-02 | 2019-07-01 | PS Planned sale |
Chief Scientific Officer |
2,500
-0.9%
14.42USD 36,051 |
2,500 -0.9% | 14.42 | USD 36,051 | |
| 2019-07-02 | 2019-07-01 | PS Planned sale |
Chief Scientific Officer |
5,000
-1.8%
14.39USD 71,933 |
5,000 -1.8% | 14.39 | USD 71,933 | |
| 2019-06-24 | 2019-06-21 | PS Planned sale |
Chief Business Officer |
5,415
-5.2%
16.07USD 87,019 |
5,415 -5.2% | 16.07 | USD 87,019 | |
| 2019-06-24 | 2019-06-21 | PS Planned sale |
See Remarks |
12,331
-3.4%
15.11USD 186,321 |
12,331 -3.4% | 15.11 | USD 186,321 | |
| 2019-06-24 | 2019-06-20 | PS Planned sale |
See Remarks |
1,669
-0.5%
15.10USD 25,202 |
1,669 -0.5% | 15.10 | USD 25,202 | |
| 2019-06-18 | 2019-06-17 | PS Planned sale |
Chief Scientific Officer |
7,500
-2.6%
13.90USD 104,267 |
7,500 -2.6% | 13.90 | USD 104,267 | |
| 2019-03-22 | 2019-03-20 | S Sale |
14,245
-100.0%
17.86USD 254,416 |
14,245 -100.0% | 17.86 | USD 254,416 | ||
| 2019-03-22 | 2019-03-20 | S Sale | Large shareholder |
14,245
-100.0%
17.86USD 254,416 |
14,245 -100.0% | 17.86 | USD 254,416 | |
| 2018-06-27 | 2018-06-25 | B Purchase |
See Remarks Executive Director |
400
+0.1%
15.00USD 6,000 |
400 +0.1% | 15.00 | USD 6,000 | |
| 2018-06-27 | 2018-06-25 | B Purchase | Non-Executive Director |
6,600
+3.0%
15.00USD 99,000 |
6,600 +3.0% | 15.00 | USD 99,000 |